Download PDF
Aktuelle Neurologie 2015; 42(05): 279-290
DOI: 10.1055/s-0035-1552650
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York

Juveniler Schlaganfall – Ätiologie, Diagnostik und Therapie

Stroke in the Young – Etiology, Diagnosis and Treatment
T. Siepmann
1   Klinik und Poliklinik für Neurologie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden
2   Institut für Klinische Pharmakologie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden
,
A. I. Penzlin
2   Institut für Klinische Pharmakologie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden
,
U. Bodechtel
1   Klinik und Poliklinik für Neurologie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden
› Author Affiliations
Further Information

Publication History

Publication Date:
30 June 2015 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Der juvenile Schlaganfall ist von der Mehrzahl der Autoren definiert als zerebraler Infarkt bei Patienten, die älter als 18 Jahre, jedoch jünger als 45 (oder 55) Jahre sind und stellt eine ätiologiediagnostische Herausforderung an den behandelnden Arzt dar. Die Angaben zur Prävalenz juveniler Schlaganfälle variieren zwischen 4,5 % und 12,3 % aller Schlaganfälle. Häufige Ursachen juveniler Schlaganfälle umfassen Makro- und Mikroangiopathien sowie kardiale Embolien. Darüber hinaus sind auch seltenere Ursachen bedeutsam u. a. hämatologische Krankheitsbilder, Drogenkonsum, orale Kontrazeption, nicht arteriosklerotische Gefäßkrankheiten, Stoffwechselerkrankungen oder Migräne. Oft bleibt die Ursache jedoch auch nach umfassender Abklärung kryptogen. Angesichts der häufig klinisch nicht vordergründig ersichtlichen Ursachen und dem breiten ätiologischen Spektrum ist bei juvenilen Schlaganfallpatienten eine umfassende diagnostische Abklärung erforderlich. Neben einer genauen Anamnese (u. a. Kopfschmerzanamnese, Substanzkonsumanamnese und Familienanamnese) und körperliche Untersuchung (u. a. dermatologische und autoimmune Stigmata) sind laborchemische (u. a. Liquorstudium und Vaskulitisserologie) und apparative Untersuchungen (u. a. Langzeit-EKG-Messung, transösophageale Echokardiografie und kranielle Magnetresonanztomografie) zielführend.

Abstract

Juvenile stroke, commonly defined as stroke in patients younger than 45 or 50 years, is diagnostically challenging. Prevalence varies between 4.5 and 12.3 % of all strokes. While frequent causes of juvenile stroke include cardiac embolism, macroangiopathies and microangiopathies, a variety of other mechanisms such as hematologic diseases, drug consumption, contraception, and migraine can also induce juvenile stroke. However, even after exhaustive diagnostic assessment, the underlying mechanism frequently remains cryptogenic. Due to its clinical heterogeneity and broad etiological spectrum, juvenile stroke requires thorough diagnostic assessment, in particular when cardiovascular risk factors are absent. Beside focused medical history (including history of headaches, drug consumption and family medical history) and physical examination (including assessment for cutaneous and autoimmune stigmata), laboratory assessment (including cerebrospinal fluid analysis and vasculitis assessment) and cardiovascular assessment (including holter ECG, transesophageal echocardiography and cranial MRI) constitute relevant diagnostic techniques in the assessment of juvenile stroke.

 

  • Literatur

  • 1 Maaijwee NA, Rutten-Jacobs LC, Schaapsmeerders P et al. Ischaemic stroke in young adults: risk factors and long-term consequences. Nat Rev Neurol 2014; 10: 315-325
    CrossrefPubMedGoogle Scholar
  • 2 Knoflach M, Furtner M, Mair A et al. Juvenile stroke – results from the Austrian Stroke Registry. Wien Med Wochenschr 2008; 158: 453-457
    CrossrefPubMedGoogle Scholar
  • 3 Bogousslavsky J, Pierre P. Ischemic stroke in patients under age 45. Neurol Clin 1992; 10: 113-124
    PubMedGoogle Scholar
  • 4 Park WB, Cho JS, Shin SD et al. Comparison of epidemiology, emergency care, and outcomes of acute ischemic stroke between young adults and elderly in Korean population: a multicenter observational study. J Korean Med Sci 2014; 29: 985-991
    CrossrefPubMedGoogle Scholar
  • 5 Nedeltchev K, de Maur TA, Georgiadis D et al. Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry 2005; 76: 191-195
    CrossrefPubMedGoogle Scholar
  • 6 von Sarnowski B, Schminke U, Tatlisumak T et al. Prevalence of stenoses and occlusions of brain-supplying arteries in young stroke patients. Neurology 2013; 80: 1287-1294
    CrossrefPubMedGoogle Scholar
  • 7 Rolfs A, Fazekas F, Grittner U et al. Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study. Stroke 2013; 44: 340-349
    CrossrefPubMedGoogle Scholar
  • 8 Krämer M, Berlit P. Der Schlaganfall beim jungen Menschen. Akt Neurol 2011; 38: 23-44
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Caplan LR, Hier DB, Banks G. Current concepts of cerebrovascular disease – stroke: stroke and drug abuse. Stroke 1982; 13: 869-872
    CrossrefPubMedGoogle Scholar
  • 10 Brust JCM. Stroke and Substance Abuse. In: Caplan L, ed. Uncommon Causes of Stroke. Cambridge: Cambridge Medicine; 2008
    CrossrefGoogle Scholar
  • 11 Nabavi DG, Allroggen A, Ringelstein EB. Juvenile ischemic brain infarction. Clinical aspects, etiology spectrum, diagnosis and therapy. Nervenarzt 2004; 75: 167-186
    CrossrefPubMedGoogle Scholar
  • 12 Kraemer M, Berlit P. Systemic, secondary and infectious causes for cerebral vasculitis: clinical experience with 16 new European cases. Rheumatol Int 2009; 201: 1471-1476
    PubMedGoogle Scholar
  • 13 Kraemer M, Berlit P. Primary central nervous system vasculitis: clinical experiences with 21 new European cases. Rheumatol Int 2011; 31: 463-472
    CrossrefPubMedGoogle Scholar
  • 14 Salvarani C, Brown Jr RD, Calamia KT et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 2007; 62: 442-451
    CrossrefPubMedGoogle Scholar
  • 15 Kittner SJ, Stern BJ, Wozniak M et al. Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998; 50: 890-894
    CrossrefPubMedGoogle Scholar
  • 16 Nabavi DG, Allroggen A, Ringelstein EB. Juvenile ischemic brain infarction. Clinical aspects, etiology spectrum, diagnosis and therapy. Nervenarzt 2004; 75: 167-186
    CrossrefPubMedGoogle Scholar
  • 17 von Sarnowski B, Putaala J, Grittner U et al. Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry Patients study. Stroke 2013; 44: 119-125
    CrossrefPubMedGoogle Scholar
  • 18 Ahn SS, Kim BM, Suh SH et al. Spontaneous symptomatic intracranial vertebrobasilar dissection: initial and follow-up imaging findings. Radiology 2012; 264: 196-202
    CrossrefPubMedGoogle Scholar
  • 19 Diener HC, Putzki N, Berlit P et al. Leitlinien für Diagnostik und Therapie in der Neurologie. 4th. ed. Stuttgart: Thieme; 2008
    Google Scholar
  • 20 Markus HS, Hayter E, Levi C et al. CADISS trial investigators. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial. Lancet Neurol 2015; 14: 361-367
    CrossrefPubMedGoogle Scholar
  • 21 Sheikh SI, Singhal AB. Extension of „roller coaster dissection“ after tissue plasminogen activator. AJNR Am J Neuroradiol 2010; 31: E4
    CrossrefPubMedGoogle Scholar
  • 22 Carolei A, Sacco S. Central nervous system vasculitis. Neurol Sci 2003; 24 (Suppl. 01) S8-S10
    CrossrefPubMedGoogle Scholar
  • 23 Salvarani C, Brown RD Jr, Calamia KT et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 2007; 62: 442-451
    CrossrefPubMedGoogle Scholar
  • 24 Kraemer M, Berlit P. Reversibles zerebrales Vasokonstriktionssyndrom versus zerebrale Vaskulitis. Der Nervenarzt 2011; 82: 500-505
    CrossrefPubMedGoogle Scholar
  • 25 Sloan MA, Kittner SJ, Feeser BR et al. Illicit drug-associated ischemic stroke in the Baltimore-Washington Young Stroke Study. Neurology 1998; 50: 1688-1693
    CrossrefPubMedGoogle Scholar
  • 26 Calabrese LH, Molloy ES, Singhal AB. Primary central nervous system vasculitis: progress and questions. Ann Neurol 2007; 62: 430-432
    CrossrefPubMedGoogle Scholar
  • 27 Kraemer M, Berlit P. Primary central nervous system vasculitis and moyamoya disease: similarities and differences. J Neurol 2010; 257: 816-819
    CrossrefPubMedGoogle Scholar
  • 28 Miller DH, Ormerod IE, Gibson A et al. MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology 1987; 29: 226-231
    CrossrefPubMedGoogle Scholar
  • 29 Iancu-Gontard D, Oppenheim C, Touze E et al. Evaluation of hyperintense vessels on FLAIR MRI for the diagnosis of multiple intracerebral arterial stenoses. Stroke 2003; 34: 1886-1891
    CrossrefPubMedGoogle Scholar
  • 30 Kadkhodayan Y, Alreshaid A, Moran CJ et al. Primary angiitis of the central nervous system at conventional angiography. Radiology 2004; 233: 878-882
    CrossrefPubMedGoogle Scholar
  • 31 Moore PM. Diagnosis and management of isolated angiitis of the central nervous system. Neurology 1989; 39: 167-173
    CrossrefPubMedGoogle Scholar
  • 32 Calabrese LH, Duna GF. Evaluation and treatment of central nervous system vasculitis. Curr Opin Rheumatol 1995; 7: 37-44
    PubMedGoogle Scholar
  • 33 Duna GF, Calabrese LH. Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol 1995; 22: 662-667
    PubMedGoogle Scholar
  • 34 Berlit P. Primary angiitis of the CNS – an enigma that needs world-wide efforts to be solved. Eur J Neurol 2009; 16: 10-11
    CrossrefPubMedGoogle Scholar
  • 35 Siepmann T, Bodechtel U. Macaroni Sign. Neurology 2014; 83: e11
    CrossrefPubMedGoogle Scholar
  • 36 Kraemer M, Berlit P. Systemic, secondary and infectious causes for cerebral vasculitis: clinical experience with 16 new European cases. Rheumatol Int 2009; 201: 1471-1476
    PubMedGoogle Scholar
  • 37 Berlit P Hrsg. Klinische Neurologie. 2.. aktualisierte Auflage. Heidelberg: Springer Verlag; 2005
    Google Scholar
  • 38 Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke 2008; 39: 3193-3200
    CrossrefPubMedGoogle Scholar
  • 39 Calamante F, Ganesan V, Kirkham FJ et al. MR perfusion imaging in Moyamoya Syndrome: potential implications for clinical evaluation of occlusive cerebrovascular disease. Stroke 2001; 32: 2810-2816
    CrossrefPubMedGoogle Scholar
  • 40 Fukui M, Kono S, Sueishi K et al. Moyamoya disease. Neuropathology 2000; 20 (Suppl. 01) S61-64
    CrossrefPubMedGoogle Scholar
  • 41 Achrol AS, Guzman R, Lee M et al. Pathophysiology and genetic factors in moyamoya disease. Neurosurg Focus 2009; 26: E4
    PubMedGoogle Scholar
  • 42 Gross BA, Thomas AJ, Frerichs KU. Endovascular treatment of symptomatic moyamoya. Neurosurg Rev 2014; 37: 579-583
    CrossrefPubMedGoogle Scholar
  • 43 Singhal AB, Koroshetz WR, Caplan LR. Reversible cerebral vasoconstriction syndromes. 2.. ed. Cambridge: University Press; 2010
    Google Scholar
  • 44 Calabrese LH, Dodick DW, Schwedt TJ et al. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 2007; 146: 34-44
    CrossrefPubMedGoogle Scholar
  • 45 Mahmud HM. Fabry’s disease – a comprehensive review on pathogenesis, diagnosis and treatment. J Pak Med Assoc 2014; 64: 189-194
    PubMedGoogle Scholar
  • 46 Siepmann T, Penzlin AI, Illigens BMW. Autonomic neuropathies. Dtsch Med Wochenschr 2013; 138: 1465-1469
    Article in Thieme ConnectPubMedGoogle Scholar
  • 47 Freeman R. Autonomic peripheral neuropathy. Lancet 2005; 365: 1259-1270
    CrossrefPubMedGoogle Scholar
  • 48 Fazekas F, Enzinger C, Schmidt R et al. MRI in acute cerebral ischemia of the young: the Stroke in Young Fabry Patients (sifap1) Study. Neurology 2013; 81: 1914-1921
    CrossrefPubMedGoogle Scholar
  • 49 Mehta A, Beck M, Eyskens F et al. Fabry disease: a review of current management strategies. QJM 2010; 103: 641-659
    CrossrefPubMedGoogle Scholar
  • 50 Chabriat H, Joutel A, Dichgans M. Cadasil. Lancet Neurol 2009; 8: 643-653
    CrossrefPubMedGoogle Scholar
  • 51 Schrag M, Greer DM. Clinical Associations of Cerebral Microbleeds on Magnetic Resonance Neuroimaging. J Stroke Cerebrovasc Dis 2014; Oct 4. pii: S1052-3057(14)00332-2. [Epub ahead of print] DOI: 10.1016/j.jstrokecerebrovasdis.2014.07.006.
    PubMedGoogle Scholar
  • 52 Joutel A, Corpechot C, Ducros A et al. Notch3 mutations in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a mendelian condition causing stroke and vascular dementia. Ann N Y Acad Sci 1997; 826: 213-217
    CrossrefPubMedGoogle Scholar
  • 53 Kraemer M, Linden D, Berlit P. The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review. J Neurol 2005; 252: 1155-1166
    CrossrefPubMedGoogle Scholar
  • 54 Tietjen GE, Al-Qasmi MM, Gunda P et al. Sneddon’s syndrome: another migraine-stroke association?. Cephalalgia 2006; 26: 225-232
    CrossrefPubMedGoogle Scholar
  • 55 Wohlrab J, Fischer M, Marsch WC. Current diagnosis of Sneddon syndrome. Dtsch Med Wochenschr 2001; 126: 725-728
    Article in Thieme ConnectPubMedGoogle Scholar
  • 56 Boesch SM, Plorer AL, Auer AJ et al. The natural course of Sneddon syndrome: clinical and magnetic resonance imaging findings in a prospective six year observation study. J Neurol Neurosurg Psychiatry 2003; 74: 542-544
    CrossrefPubMedGoogle Scholar
  • 57 Floel A, Imai T, Lohmann H et al. Therapy of Sneddon syndrome. Eur Neurol 2002; 48: 126-132
    CrossrefPubMedGoogle Scholar
  • 58 Frances C, Piette JC. The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus. J Autoimmun 2000; 15: 139-143
    CrossrefPubMedGoogle Scholar
  • 59 Greenberg SM, Vonsattel JP, Stakes JW et al. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993; 43: 2073-2079
    CrossrefPubMedGoogle Scholar
  • 60 Chant H, McCollum C. Stroke in young adults: the role of paradoxical embolism. Thromb Haemost 2001; 85: 22-29
    PubMedGoogle Scholar
  • 61 Windecker S, Stortecky S, Meier B. Paradoxical embolism. J Am Coll Cardiol 2014; 64: 403-415
    CrossrefPubMedGoogle Scholar
  • 62 Meier B, Kalesan B, Mattle HP et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013; 368: 1083-1091
    CrossrefPubMedGoogle Scholar
  • 63 Carroll JD, Saver JL, Thaler DE et al. Closure of patent foramen ovale versus medical therapy. N Engl J Med 2013; 368: 1092-1100
    CrossrefPubMedGoogle Scholar
  • 64 Yoshida T, Ouchi A, Miura D et al. MELAS and reversible vasoconstriction of the major cerebral arteries. Intern Med 2013; 52: 1389-1392
    CrossrefPubMedGoogle Scholar
  • 65 Koga Y, Povalko N, Nishioka J et al. MELAS and L-arginine therapy: pathophysiology of stroke-like episodes. Ann N Y Acad Sci 2010; 1201: 104-110
    CrossrefPubMedGoogle Scholar
  • 66 Sue CM, Quigley A, Katsabanis S et al. Detection of MELAS A3243G point mutation in muscle, blood and hair follicles. J Neurol Sci 1998; 161: 36-39
    CrossrefPubMedGoogle Scholar
  • 67 Jones EF, Calafiore P, Donnan GA et al. Evidence that patent foramen ovale is not a risk factor for cerebral ischemia in the elderly. Am J Cardiol 1994; 74: 596-599
    CrossrefPubMedGoogle Scholar
  • 68 Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306
    CrossrefPubMedGoogle Scholar
  • 69 Janardhan V, Wolf PA, Kase CS et al. Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study. Stroke 2004; 35: 736-741
    CrossrefPubMedGoogle Scholar
  • 70 Crowther MA, Ginsberg JS, Julian J et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003; 349: 1133-1138
    CrossrefPubMedGoogle Scholar
  • 71 Levine SR, Brey RL, Tilley BC et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004; 291: 576-584
    CrossrefPubMedGoogle Scholar
  • 72 Tosetto A, Ruggeri M, Castaman G et al. Inherited abnormalities of blood coagulation in juvenile stroke. A case-control study. Blood Coagul Fibrinolysis 1997; 8: 397-402
    CrossrefPubMedGoogle Scholar
  • 73 Cerrato P, Imperiale D, Bazzan M et al. Inherited thrombophilic conditions, patent foramen ovale and juvenile ischaemic Stroke. Cerebrovasc Dis 2001; 11: 140-141
    CrossrefPubMedGoogle Scholar
  • 74 Reynolds K, Lewis B, Nolen JD et al. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003; 289: 579-588
    CrossrefPubMedGoogle Scholar
  • 75 Kurth T, Tzourio C. Migraine and cerebral infarct-like lesions on MRI: an observation, not a disease. JAMA 2009; 301: 2594-2595
    CrossrefPubMedGoogle Scholar
  • 76 Guidetti D, Rota E, Morelli N et al. Migraine and stroke: “vascular” comorbidity. Front Neurol 2014; 5: 193
    PubMedGoogle Scholar